glipizide has been researched along with pioglitazone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 10 (43.48) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agarwal, R; Battiwala, M; Chase, SD; Curley, T; Sachs, N; Saha, C; Semret, MH; Vasavada, N | 1 |
| Asrat, L; Kaul, CL; Ramarao, P; Srinivasan, K; Viswanad, B | 1 |
| Digman, C; Klein, AK; Pittas, AG | 1 |
| Bodary, PF; Eitzman, DT; Jongeward, KL; King, SA; Vargas, FB; Wickenheiser, KJ | 1 |
| Basu, A; Jensen, MD; Joyner, MJ; McCann, F; Mukhopadhyay, D; Rizza, RA | 1 |
| Choudhury, H; Harisudhan, T; Mullangi, R; Srinivas, NR; Venkatesh, P | 1 |
| Albrecht, H; Hug, H; Kersten, S; Meyer, UA; Podvinec, M; Roth, A; Rücker, C; Scarsi, M; Schwede, T | 1 |
| Agarwal, R | 1 |
| Bussel, II; Felgner, J; Jafari, M; Khodayari, B; Mueller, LD; Rose, MR | 1 |
| Drucker, DJ; Goldberg, RB; Holman, R | 1 |
| Halperin, F; Ingelfinger, JR; McMahon, GT | 1 |
| Basu, A; Basu, R; Jensen, MD; Pattan, V; Rizza, RA | 1 |
| AbuKhader, MM; Alqtaishat, S; Khanfar, MA; Taha, MO | 1 |
| Khatu, S; Poojary, S | 1 |
| Chen, C; Chen, RP; Li, SM; Ren, A; Xiao, CC; Xing, XN; Yang, J; Ye, SD | 1 |
| El-Zaher, AA; Elkady, EF; Elwy, HM; Saleh, MA | 1 |
| Adanichkin, N; Campbell, JM; Kurmis, R; Munn, Z | 1 |
| Abdul-Ghani, MA; Adams, AC; Adams, J; Cersosimo, E; Cheng, CC; DeFronzo, RA; Fourcaudot, M; Heikkinen, S; Khattab, A; Norton, L; Puckett, C; Samms, RJ; Triplitt, C; Tsintzas, K | 1 |
| Jannetto, PJ; Langman, LJ | 1 |
2 review(s) available for glipizide and pioglitazone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Intensive insulin therapy, insulin sensitisers and insulin secretagogues for burns: A systematic review of effectiveness and safety.
Topics: Burns; Dipeptidyl-Peptidase IV Inhibitors; Disease Management; Exenatide; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Metformin; Pioglitazone; Rosiglitazone; Secretagogues; Sulfonylurea Compounds | 2018 |
6 trial(s) available for glipizide and pioglitazone
| Article | Year |
|---|---|
A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Middle Aged; Pilot Projects; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2005 |
Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Composition; Body Fat Distribution; Body Water; Diabetes Mellitus, Type 2; Female; Glipizide; Glycated Hemoglobin; Hemodynamics; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2006 |
Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
Topics: Aged; Biomarkers; Blood Urea Nitrogen; Chromatography, High Pressure Liquid; Contrast Media; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Follow-Up Studies; Glipizide; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Iothalamic Acid; Male; Pioglitazone; Prognosis; Renal Plasma Flow; Thiazolidinediones; Urodynamics | 2007 |
Meal fat storage in subcutaneous adipose tissue: comparison of pioglitazone and glipizide treatment of type 2 diabetes.
Topics: Biopsy; Carbon Isotopes; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Fats; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Subcutaneous Fat; Thiazolidinediones; Triolein | 2010 |
Effects of pioglitazone and glipizide on platelet function in patients with type 2 diabetes.
Topics: Blood Platelets; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Glipizide; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Platelet Activation; Thiazolidinediones; Treatment Outcome | 2015 |
FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Exenatide; Fibroblast Growth Factors; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Peptides; Pioglitazone; Thiazolidinediones; Venoms | 2022 |
15 other study(ies) available for glipizide and pioglitazone
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Dietary Fats; Glipizide; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Streptozocin; Thiazolidinediones; Triglycerides | 2005 |
Leukopenia and thrombocytopenia caused by thiazolidinediones.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Humans; Hypoglycemic Agents; Leukopenia; Middle Aged; Pioglitazone; Rosiglitazone; Thiazolidinediones; Thrombocytopenia | 2005 |
Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance.
Topics: Animals; Carotid Arteries; Disease Models, Animal; Drug Evaluation, Preclinical; Glipizide; Insulin Resistance; Mice; Obesity; P-Selectin; Pioglitazone; Platelet Aggregation Inhibitors; Thiazolidinediones; Thrombosis | 2005 |
Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human p
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Pioglitazone; Piperidines; Reproducibility of Results; Rosiglitazone; Thiazolidinediones | 2006 |
Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach.
Topics: ATP-Binding Cassette Transporters; Computer Simulation; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Gene Expression Regulation; Glipizide; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Pioglitazone; Potassium Channels; Potassium Channels, Inwardly Rectifying; PPAR gamma; Protein Binding; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Thiazolidinediones | 2007 |
Pioglitazone: an anti-diabetic compound with anti-aging properties.
Topics: Animals; Basal Metabolism; Dose-Response Relationship, Drug; Drosophila melanogaster; Fertility; Glipizide; Hypoglycemic Agents; Insulin; Longevity; Metformin; Models, Biological; Pioglitazone; Population Density; Research Design; Rosiglitazone; Sexual Behavior, Animal; Signal Transduction; Thiazolidinediones; Time Factors | 2007 |
Clinical decisions. Management of type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glipizide; Glucagon-Like Peptide 1; Humans; Hypertension; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Obesity; Pioglitazone; Thiazolidinediones | 2008 |
Clinical decisions. Management of type 2 diabetes--polling results.
Topics: Body Weight; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin, Isophane; Metformin; Peptides; Pioglitazone; Thiazolidinediones; Venoms | 2008 |
Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.
Topics: Adrenergic beta-Antagonists; Amino Acid Sequence; Anti-Infective Agents; Catalytic Domain; Crystallography, X-Ray; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metipranolol; Models, Molecular; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Pioglitazone; Quantitative Structure-Activity Relationship; ROC Curve; Sequence Alignment; Sotalol; Sulfamethizole; Thiazolidinediones; TOR Serine-Threonine Kinases | 2013 |
Disseminated cryptococcosis in a diabetic patient.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Fluconazole; Glipizide; Humans; Hypoglycemic Agents; Immunocompromised Host; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2014 |
Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine).
Topics: Carbamates; Chromatography, High Pressure Liquid; Drug Contamination; Glipizide; Guanidines; Hypoglycemic Agents; Metformin; Pioglitazone; Piperidines; Sulfonylurea Compounds; Thiazolidinediones | 2016 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |